Status:
COMPLETED
Oncology Care Pathway's Modifications Impact During COVID-19 Pandemic : the ONCOCARE-COV Study
Lead Sponsor:
CHU de Reims
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
In december 2019, SARS-CoV2 and its clinical manifestations, COVID-19, appeared in China and caused a pandemic. It led decision makers to prioritize emergency and intensive care dedicated to infection...
Detailed Description
Quantitative monthly data were analyzed from January 1, 2019 to May 31, 2020 in two French tertiary care center (University Hospital and Godinot Cancer Institute in Reims) and in a third center in the...
Eligibility Criteria
Inclusion
- Every adult patient entering an oncology care pathway between 01/01/2019 and 31/12/2020
Exclusion
- \<18 yo
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04445870
Start Date
May 1 2020
End Date
December 31 2021
Last Update
July 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Reims
Reims, France, 51092